Intravenous mesenchymal stem cells prevented rejection of allogeneic corneal transplants by aborting the early inflammatory response.
Academic Article
-
- Overview
-
- Research
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
published proceedings
author list (cited authors)
-
Oh, J. Y., Lee, R. H., Yu, J. M., Ko, J. H., Lee, H. J., Ko, A. Y., Roddy, G. W., & Prockop, D. J.
publication date
publisher
published in
Research
keywords
-
Administration, Intravenous
-
Animals
-
Anti-Inflammatory Agents
-
Antigen-Presenting Cells
-
Cell Adhesion Molecules
-
Cells, Cultured
-
Cornea
-
Corneal Transplantation
-
Female
-
Gene Knockdown Techniques
-
Graft Rejection
-
Histocompatibility Antigens Class II
-
Humans
-
Inflammation Mediators
-
Lung
-
Lymph Nodes
-
Macrophages
-
Mesenchymal Stem Cell Transplantation
-
Mesenchymal Stem Cells
-
Mice
-
Mice, Inbred C57BL
-
NF-kappa B
-
RNA, Small Interfering
-
Signal Transduction
-
Transcriptome
-
Transplantation, Homologous
Identity
PubMed Central ID
Digital Object Identifier (DOI)
Additional Document Info
start page
end page
volume
issue
